Patent · US Active

Tubulysins and protein-tubulysin conjugates

US12144864B2 · kind B2 · utility

0Cited by
7References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2019
Grant dateNov 19, 2024
Priority date
Expiry dateJan 8, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/021
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds, compositions, and methods for the treatment of diseases and disorders associated with cancer, including tubulysins and protein (e.g., antibody) drug conjugates thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.